Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris

Pei Feng Liu, Yao Dung Hsieh, Ya Ching Lin, Aimee Two, Chih Wen Shu, Chun Ming Huang

研究成果: 雜誌貢獻回顧評介論文同行評審

26 引文 斯高帕斯(Scopus)

摘要

Acne vulgaris, a multi-factorial disease, is one of the most common skin diseases, affecting an estimated 80% of Americans at some point during their lives. The gram-positive and anaerobic Propionibacterium acnes (P. acnes) bacterium has been implicated in acne inflammation and pathogenesis. Therapies for acne vulgaris using antibiotics generally lack bacterial specificity, promote the generation of antibiotic-resistant bacterial strains, and cause adverse effects. Immunotherapy against P. acnes or its antigens (sialidase and CAMP factor) has been demonstrated to be effective in mice, attenuating P. acnes-induced inflammation; thus, this method may be applied to develop a potential vaccine targeting P. acnes for acne vulgaris treatment. This review summarizes reports describing the role of P. acnes in the pathogenesis of acne and various immunotherapy-based approaches targeting P. acnes, suggesting the potential effectiveness of immunotherapy for acne vulgaris as well as P. acnes-associated diseases.

原文???core.languages.en_GB???
頁(從 - 到)245-254
頁數10
期刊Current Drug Metabolism
16
發行號4
DOIs
出版狀態已出版 - 1 9月 2015

指紋

深入研究「Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris」主題。共同形成了獨特的指紋。

引用此